Increase the levothyroxine dose by 12.5 to 25 mcg
This patient has inadequately treated primary hypothyroidism (TSH 7.19 mIU/L on 100 mcg levothyroxine) and requires a dose increase to achieve biochemical euthyroidism.
Rationale for Dose Adjustment
The FDA-approved levothyroxine prescribing information explicitly states that for adults with hypothyroidism, you should "titrate dosage by 12.5 to 25 mcg increments every 4 to 6 weeks, as needed until the patient is euthyroid" 1. Since this patient's TSH is elevated above the normal range despite being on therapy, she is not yet euthyroid and requires dose escalation.
The target is normalization of serum TSH to the reference range 1. For primary hypothyroidism, TSH is the appropriate monitoring parameter (unlike secondary/tertiary hypothyroidism where free T4 should guide therapy) 1.
Specific Dosing Recommendation
- Increase from 100 mcg to either 112.5 mcg or 125 mcg daily
- Recheck TSH in 6-8 weeks after the dose change 1
- Continue adjusting by 12.5-25 mcg increments until TSH normalizes
At age 67, this patient falls into the geriatric category where the FDA label recommends a "lower starting dose" initially 1, but she is already established on therapy. The standard titration increments still apply.
Important Considerations Before Adjusting
Before increasing the dose, verify:
- Medication adherence - Poor compliance is a common cause of elevated TSH 1, 2
- Timing of administration - LT4 should be taken on an empty stomach, ideally 30-60 minutes before breakfast
- Interfering medications or supplements - Calcium, iron, proton pump inhibitors, bile acid sequestrants, and many other agents impair absorption 2
- Gastrointestinal disorders - Celiac disease, H. pylori infection, atrophic gastritis, inflammatory bowel disease can reduce absorption 2
- Recent weight gain - Increased body weight increases levothyroxine requirements 3
Monitoring Strategy
After dose adjustment, recheck TSH in 6-8 weeks 1. The peak therapeutic effect of a levothyroxine dose change takes 4-6 weeks to manifest 1, so earlier testing may be misleading.
Once TSH is normalized and stable, patients on doses ≤125 mcg/day can be monitored every 6-12 months 1. Research suggests that patients on lower doses (≤125 mcg/day) have more stable TSH values over time, with 91% maintaining normal TSH at one year compared to only 73% of those on higher doses 4.
Common Pitfalls to Avoid
- Don't assume the current dose is adequate just because T3 and T4 are "normal" - TSH is the primary marker for dose adequacy in primary hypothyroidism
- Don't overlook malabsorption - If TSH remains elevated despite dose increases >300 mcg/day, this suggests poor compliance, malabsorption, or drug interactions 1
- Don't adjust doses too frequently - Wait the full 4-6 weeks for steady state before rechecking labs
- Don't ignore cardiac risk factors - While this patient is 67, if she has underlying cardiac disease or atrial fibrillation risk, titrate more slowly (every 6-8 weeks rather than 4-6 weeks) 1
The normal T3 and T4 levels in the setting of elevated TSH indicate subclinical hypothyroidism that is undertreated, not adequately controlled disease. The goal remains TSH normalization through appropriate dose titration 1, 5.